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Summary and the retina (Usher 1914). Variations in severity of
hearing loss and vestibular response among affected
Usher syndrome types I (USH1A–USH1E) are a group families distinguish between three different Usher phe-
of autosomal recessive diseases characterized by pro- notypes, known as Usher type 1 (USH1), Usher type 2
found congenital hearing loss, vestibular areﬂexia, and (USH2), and Usher type 3 (USH3) (Moller et al. 1989;
progressive visual loss due to retinitis pigmentosa. The Smith et al. 1992b; Sankila et al. 1994). On the basis
human myosin VIIA gene, located on 11q14, has been of phenotypic differences, genetic heterogeneity was hy-
shown to be responsible for Usher syndrome type 1B pothesized (Davenport and Omenn 1977) and has been
(USH1B). Haplotypes were constructed in 28 USH1 veriﬁed recently by linkage studies. USH1 shows linkage
families by use of the following polymorphic markers to at least ﬁve different loci: chromosome 14q (USH1A;
spanning the USH1B locus: D11S787, D11S527, Kaplan et al. 1992), chromosome 11q (USH1B; Kimber-
D11S1789, D11S906, D11S4186, and OMP. Affected ling et al. 1992), chromosome 11p (USH1C; Smith et
individuals and members of their families from 12 differ- al. 1992a), chromosome 10q (USH1D; Wayne et al.
ent ethnic origins were screened for the presence of mu- 1996), and chromosome 21q (USH1E; Chaib et al.
tations in all 49 exons of the myosin VIIA gene. In 15 1997). USH1B is the most common subtype, accounting
families myosin VIIA mutations were detected, verifying for Ç70% of all type 1 cases. The myosin VIIA gene
their classiﬁcation as USH1B. All these mutations are was determined to be responsible for USH1B, on the
novel, including three missense mutations, one prema- basis of the detection of nonsense and missense muta-
ture stop codon, two splicing mutations, one frameshift, tions and two small deletions in the head region of the
and one deletion of ú2 kb comprising exons 47 and 48, gene in three affected families (Weil et al. 1995). Simi-
a part of exon 49, and the introns between them. Three larly, mutations in the murine myosin VIIA gene were
mutations were shared by more than one family, consis- shown to be responsible for the shaker-1 phenotype
tent with haplotype similarities. Altogether, 16 USH1B (Gibson et al. 1995). Immunolocalization showed that
haplotypes were observed in the 15 families; most haplo- the myosin VIIA protein is expressed within tissues in-
types were population speciﬁc. Several exonic and in- volved in the Usher syndrome pathology: inner and
tronic polymorphisms were also detected. None of the outer hair cells of the organ of Corti of the guinea pig
20 known USH1B mutations reported so far in other and retinal pigment epithelium (RPE) in adult rat (Has-
world populations were identiﬁed in our families. son et al. 1995). A species-speciﬁc cell pattern of gene
expression was suggested as a possible cause for the
discrepancy between the human USH1B and the mouseIntroduction
shaker-1 phenotypes, which both manifest themselves
The Usher syndromes (USH) are a group of genotypi- by cochlear and vestibular dysfunction and differ be-
cally distinct diseases that share several phenotypic char- tween each other in retinal dystrophy, which is absent in
acteristics and are recognized as the most frequent cause the mouse shaker-1 phenotype (El-Amraoui et al. 1996).
of hereditary deafness-blindness in humans. These syn- Screening of the ﬁrst 14 exons of the human myosin
dromes are characterized by autosomal recessive inheri- VIIA yielded 14 mutations, of which 12 were novel, in
tance and by dual sensory impairments of the inner ear 21 different families (Weston et al. 1996; Liu et al.
1997). Another screening, covering 48 of the gene’s 49
exons, detected eight mutations, of which four were
novel, in six different families (Levy et al. 1997). ThisReceived April 10, 1997; accepted for publication July 8, 1997.
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Subjects and Methods extraction kit, and used as templates in a direct cycle-
sequencing reaction by FMC’s SequiTherm EXELTM
Subjects DNA sequencing kit. Sequencing products were sub-
Altogether, 54 affected individuals representing 28 jected to comparative electrophoresis through FMC’s
different USH1 families were referred to us through the Long RangerTM gel. Comparative electrophoresis in
Center for Deaf-Blind persons in Tel-Aviv, as part of a which normal and shifted sequencing products are elec-
larger study on the genetics of Usher syndrome in Israel. trophoresed side by side (normal ddGTP product next
Patients were considered as Usher type 1 on the basis of to shifted ddGTP product, normal ddATP product next
the presence of congenital severe hearing loss, vestibular to shifted ddATP product, etc.) enables a fast and easy
areﬂexia, and retinal degeneration. Clinical conﬁrma- detection of homozygous and heterozygous sequence
tion of this diagnosis was available for only 11 families. changes.
The origins of the 28 families are Algerian (two), Bulgar- ASO analysis.—When a change was found in a DNA
ian (one), Hungarian (three), Iranian (two), Moroccan sample from a patient, its occurrence was determined
(seven), Romanian (two), Russian (two), Samaritan among ú100 unrelated individuals by use of the allele-
(one), Tunisian (two), Yemenite (one), Hungarian-Bul- speciﬁc oligonucleotide (ASO) hybridization technique
garian (one), Polish-German (two), Polish-Latvian (one), as described by Whitney et al. (1993).
and Romanian-Russian (one). Southern blot analysis.—Genomic DNAs of affected
individuals in whom no mutation was detected by SSCP
Haplotype Analysis analysis were digested separately by several restriction
Haplotypes were derived by use of the following poly- enzymes, electrophoresed through 0.8% agarose gel,
morphic markers: D11S787, D11S527, OMP, and transferred to Qiagen nylon membrane. Filters were
D11S1789, D11S906, and D11S4186 (listed according hybridized overnight at 65C with four P32-labeled
to their physical order, from the centromeric to the te- probes comprising four different myosin VIIA exons,
lomeric end), spanning the USH1B locus. Genomic DNA were washed at 60C, and were autoradiographed at
extracted from blood of affected individuals and their 080C by use of x-ray ﬁlms.
family members was used as template. PCR ampliﬁca-
tion of these markers was performed by use of pairs of Results
speciﬁc primers as described by Sambrook et al. (1989).
Haplotype and Linkage AnalysesAlleles of each marker were numbered according to their
relative mobility on a denaturing formamide/4% acryl- Haplotypes comprising six markers listed above were
amide gel. Allele sizes were determined by comparing characterized in all affected and normal chromosomes
their mobility through Long RangerTM gel (FMC Bio- studied in this work. In the Samaritan kindred, linkage
products) with the mobility of a known DNA fragment. analysis yielded a high maximum LOD score of 11.61
(Bonne-Tamir et al. 1994), and, in ﬁve other families,
Mutation Detection linkage analysis yielded maximum LOD scores of 1.06–
2.36 . In other families, linkage results were limitedSSCP screening.—Genomic DNA extracted from
blood of affected individuals and their family members because of the small number of members available for
typing. USH1B haplotypes presented in table 1 includewas screened for mutations within the myosin-VIIA
gene, by the use of SSCP analysis (Shefﬁeld et al. 1993) haplotypes of chromosomes in which myosin VIIA mu-
tations were detected, except for haplotype 13, whichof individually ampliﬁed exons. The screen included 49
exons covering the entire open reading frame of the gene was carried by two affected brothers who are compound
heterozygotes for a paternal chromosome representedand 5 and 3 UTRs of the cDNA. All PCR products
were ampliﬁed from genomic DNA in the presence of by haplotype 12. Haplotype 13 represents two chromo-
somes, one recombinant and one original USH1B mater-radioactive end-labeled primers, under different PCR
conditions as calibrated for each exon. These products nal chromosome.Markers and intragenic polymorphism
similarities indicate that the recombination event in onewere electrophoresed through MDETM (AT Biochem)
gels containing 10% glycerol, at 800 V for 16–20 h. of these two haplotypes had occurred in the chromo-
somal interval between the myosin VIIA gene and theNucleotide sequences of primers used for the ampliﬁca-
tion of the myosin VIIA exons were as described by OMP locus. Haplotypes 1–11 and 16 were found in a
homozygous state because of the consanguineous natureWeston et al. (1996), for exons 1–14, and as described
by Levy et al. (1997), for exons 15–49 (which, in Levy et of their pedigrees. Haplotype 4 was found in three unre-
lated Jewish families, all of whose parents came from theal.’s study, are referred to as exons 14–48, respectively).
DNA sequencing.—In order to deﬁne mutations/se- same town in Morocco. This haplotype and its variants,
represented by haplotypes 1–5, seem to be the mostquence changes, DNA fragments that exhibited mobility
shifts in SSCP analysis, as well as normal fragments, common (50%) among northern African USH1B chro-
mosomes tested in this work.were reampliﬁed, gel puriﬁed by use of the Qiagen gel
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Table 1
Haplotypes of USH1B Chromosomes
ALLELE OF MARKERb
HAPLOTYPEa D11S787 D11S527 OMP (Myosin VIIA)c D11S1789 D11S906 D11S4186 ORIGIN(S)
1 8 2 3 4 2 2 Algeria
2 8 2 3 4 2 1 Algeria, Morocco
3 8 6 3 4 2 2 Algeria
4d 8 6 3 4 2 1 Morocco
5 7 7 4 4 2 1 Morocco
6 9 5 4 3 2 6 Morocco
7 7 3 4 3 2 6 Morocco
8 5 9 3 3 2 6 Morocco
9 6 8 1 5 2 6 Tunis
10e 8 1 1 5 2 10 Tunis
11 4 5 3 8 2 10 Iran
12 6 3 3 8 2 10 Bulgaria
13 6/5 3/7 3/4 5 2 10 Hungary
14 7 0 1 3 2 6 Poland
15 7 0 1 3 2 8 Latvia
16 5 7 1 5 4 5 Samaria
a Extra spaces between rows have been used to group haplotypes in which the same mutation was detected.
b Sizes of speciﬁc alleles listed in this table are as follows: D11S787 (size range of known alleles is 168–184 bp) 4 Å 178 bp; 5 Å 176 bp;
6 Å 174 bp; 7 Å 172 bp; 8 Å 170 bp; and 9 Å 168 bp; D11S527 (range 144–162 bp) 0 Å 162 bp; 1 Å 160 bp; 2 Å 158 bp; 3 Å 156 bp; 5
Å 152 bp; 6 Å 150 bp; and 7 Å 148 bp; OMP (range 256–262 bp) 1 Å 262 bp; 3 Å 258 bp; and 4 Å 256 bp; D11S1789 (range 238–258
bp) 3 Å 254 bp; 4 Å 252 bp; 5 Å 250 bp; and 8 Å 244 bp; D11S906 (range 287–295 bp) 2 Å 293 bp and 4 Å 289 bp; and D11S4186 (range
165–175 bp) 1 Å 174 bp; 2 Å 173 bp; 5 Å 170 bp; 6 Å 169 bp; 8 Å 167 bp; and 10 Å 165 bp.
c According to a Yac contig constructed in our laboratory (Seroussi et al. 1994), the position of the myosin VIIA gene was established as
being between markers OMP and D11S1789.
d Haplotype 4 was found in three unrelated Jewish families, all parents of which came from the same town in Morocco.
e Haplotype 10 is from a non-Jewish family that resides in Tunisia.
Mutation Screening mutations were found in the heterozygous state as fol-
lows: two affected brothers of Bulgarian-Hungarian ori-Mutation screening was performed on members of
gin were heterozygous for the AlarAsp mutation inall 28 USH1 families studied in this work. Eight novel
exon 11, and another patient of Moroccan origin, amutations were identiﬁed in a total of 42 affected indi-
cousin of the homozygote for the missense mutation inviduals from 15 families (see appendix), verifying their
exon 7, was a compound heterozygote for the GlyrArgclassiﬁcation as USH1B. Table 2 summarizes the muta-
and AlarThr substitutions in exons 7 and 21, respec-tions observed in this study. Codon numbering starts
tively. The GlyrArg mutation in exon 7 and thewith the ﬁrst in-frame methionine of the human myosin
AlarThr mutation in exon 21 were not observed amongVIIA (Weil et al. 1996).
ú200 control chromosomes tested by ASO analysis forA. Missense mutations.—Altogether, three missense
the presence of these mutations. The AlarAsp mutationmutations were identiﬁed among carriers and affected
in exon 11 was observed only in 1 of ú200 controlin nine unrelated families: GlyrArg in exon 7, AlarAsp
chromosomes tested by ASO analysis.in exon 11, and AlarThr in exon 21. These missense
B. Nonsense mutation.—One mutation that leads tomutations were found in the homozygous state as fol-
a premature stop codon was found in a homozygouslows: 1 patient of Moroccan origin was homozygous
state in 16 affected members of one large Samaritanfor the GlyrArg substitution in exon 7, 2 affected broth-
kindred described by Bonne-Tamir et al. (1994). This isers of Iranian origin were homozygous for the AlarAsp
a CrT transition at codon 1861 in exon 40, causing anmutation in exon 11, and 13 patients from six different
Argrstop codon (CGArTGA), which would result in afamilies of Moroccan and Algerian origins were homo-
zygous for the AlarThr mutation in exon 21. These truncated protein that lacks ú25% of tail domain.
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Table 2
Summary of Myosin VIIA Mutations Detected in USH1B Patients
Mutation Exon(s) Nucleotide Change Genotype(s) Haplotype(s) Origin(s)
Missense:
Gly214Arg 7 GGArAGA homozygote, Compound heterozygote 8 Morocco
Ala397Asp 11 GCCrGAC homozygote, Compound heterozygote 11, 12 Bulgaria, Iran
Ala826Thr 21 GCCrACC homozygote, Compound heterozygote 1, 2, 3, 4, 5 Algeria, Morocco
Nonsense:
Arg1861stop 40 CGArTGA homozygote 16 Samaria
Deletion:
2065delC 45 delCCC homozygote 6, 7 Morocco
2119–2215del2kba 47–49 ú2-kb deletion homozygote 9 Tunis
Splicing:
IVS5/1grab 5 AGgtgrAGatg homozygote 10 Tunis
IVS18/1grab 18 AGgtgrAGatg homozygote 14, 15 Poland, Latvia
a del2kb Å large genomic deletion including intronic sequences.
b IVS Å intronic splicing mutation.
C. Deletions.—Two different deletions were identi- origin. The second splice mutation is also a GrA transi-
tion, at position /1 in the splice-donor region of exonﬁed among members of three unrelated families. One
18. This mutation was observed in a homozygous statedeletion, which is a single cytosin deletion at codon 2065
in one patient of a nonconsanguineous family in whichin exon 45, was found in a homozygous state in three
one parent originated from Poland and the other origi-patients from two families of Moroccan origin. The sec-
nated from Latvia. These mutations were not observedond was a large genomic deletion of ú2 kb, including
among ú200 control chromosomes tested by ASO anal-all the translated part of exons 47–49 and the introns
ysis.between them. This deletion was found in a homozygous
state in two affected sisters of a Jewish Tunisian family
and in a heterozygous state in their parents and children.
A 1.4-kb deleted fragment was PCR ampliﬁed from both
affected sisters, by use of the forward primer of exon
46 and a reverse primer derived from the internal se-
quence of exon 49. This deletion fragment was reverse
sequenced and compared with the reverse sequence of
two fragments ampliﬁed from normal controls: one frag-
ment including exon 49 and another fragment including
exons 46–47. As shown in ﬁgure 1, this comparison
enabled the determination of the deletion borders on the
genomic sequence. The deletion starts Ç20 nucleotides
upstream from the beginning of exon 47 and ends at
nucleotide 7079, which is 249 nucleotides downstream
from the beginning of exon 49, including its entire cod-
ing region. Sequencing results revealed two different
small repeats (TGGGCC and TGATG) in the normal
genomic sequence near both edges of the deletion: three
nucleotides downstream from the edge in the end of
intron 46 and three nucleotides upstream from the edge
Figure 1 PCR cycle-sequencing results for three different DNA
in exon 49. Only one copy of these repeats is present in fragments: exon 47 PCR product ampliﬁed from genomic DNA of a
the deleted fragment. normal individual (47R(N)), deleted exon 49–exon 46 PCR product
ampliﬁed from genomic DNA of an affected individual from the JewishD. Splice-site mutations.—Two splice mutations
Tunisian family (49R(Del)), and exon 49 PCR product ampliﬁed fromwere detected among members of two unrelated fami-
genomic DNA of a normal individual (49R(N)). These DNA fragmentslies. The ﬁrst is a GrA transition at position /1 (the
were sequenced by use of the reverse primers of exons 47 and 49.
ﬁrst intronic nucleotide in the splice-donor site of exon Arrows indicate the end of homology, which continues along the
5). This mutation was observed in a homozygous state thicker lines between the 2-kb deleted fragment and the normal se-
quence.in two siblings of one family of non-Jewish Tunisian
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In 13 of the 28 USH1 families included in this study no cur in consensus splice sites; they are not analogous to
any splice mutations known in the literature, and cDNAmyosin VIIA mutations were detected. Several Southern
blot analyses were performed by use of various restric- analysis was not carried out. Therefore, we considered
these two intronic changes as polymorphisms. The com-tion enzymes, in order to detect the presence of hemizy-
gous large deletions that are undetectable by SSCP mon deletion of 22 nucleotides (ggaggcggggacaccagg-
gcct) observed in the intronic region following exon 27screening. At present, no such deletions have been identi-
ﬁed. might be associated with the case of alternative splicing
products that share the ﬁrst 27 exons of the large tran-E. Polymorphisms.—Several base substitutions (exo-
nic and intronic), one small intronic deletion, and one script reported by Chen et al. (1996) and Kelley et al.
(1996).small intronic insertion were detected and deﬁned by
SSCP and sequencing analyses, in both affected and con-
trol samples (table 3). Some shifts observed by SSCP Discussion
were not sequenced to determine the nature of their
change; therefore, there are more polymorphisms than In this study, we have characterized USH1B haplo-
types and mutations among a relatively small numberthose listed in table 3. Polymorphisms detected in several
different chromosomes are referred to as ‘‘common’’ in of families, most (13 of 15) of whom are Jewish. In
diseases such as USH1B, in which the responsible genethe origin category of table 3. Two amino acid changes,
I205V and I1954L in exons 7 and 43, respectively, are has already been identiﬁed, haplotype analysis provides
an additional means for the characterization of diseaserare and segregate with USH1B chromosomes. How-
ever, both changes are conservative; in the case of chromosomes and mutations. An example of this is the
case of haplotype 1, in which the SSCP results were notI205V, the change increases homology to the conserved
heptapeptide of human and pig myosin VI and to the clear enough to indicate the presence of mutation in any
of the 49 screened exons; however, the close homologymyosin II consensus (Weil et al. 1995), and the I1954L
change is found in cis with the R1861X nonsense muta- with haplotype 2 (in two other families, one of which
was of the same ethnic origin) led us to sequence andtion. Two intronic substitutions, IVS12/8gra and
IVS16/14ggraa (in introns 12 and 16, respectively), detect the same mutation in exon 21. Most haplotypes
constructed are population speciﬁc. Common mutationsare also rare and segregate with the disease chromo-
somes of USH1 families in which no myosin VIIA muta- and partial similarities between haplotypes were ob-
served in individuals from the same or geographicallytions were detected. However, these changes do not oc-
Table 3
Summary of Myosin VIIA Polymorphisms
Exon-Speciﬁc
Polymorphism PCR Product Nucleotide Change Origin(s)a Frequencyb
IIe156IIe 5 ATCrATT Morocco, Samaria 2/55
Ile205Val 7 ATCrGTC Russia 1/55
IVS12/8grac 12d CAGgt accgc(gra)tg Romania 1/55
IVS16/14ggraac 16 ATGgt...cct(ggraa)ggt Hungary 1/55
IVS27/10del22nucleotidesc 27 CCGgt...cg(Dgg...ct)ga Common 20/55
Ser1358Ser 31 TCCrTCT Bulgaria, Iran 2/55
IVS32/34g/tc 32 AAGgt...gat(g/t)tg Common 21/55
Ser1585Ser 35e AGTrAGC Common 15/55
IV36/21crta 36 GTGgt...gtgg(crt)aga Romania 1/55
Lys1905Lys 41e AAGrAAA Common 20/55
Ile1954Leu 43 ATCrCTC Samaria 1/55
IVS42–7a/tc 43 tg(a/t)ccccagGTC Common 23/55
IVS42–26ins ttgagc 43 ag(rttgag)gt...cagGTC Russia 2/55
Ser2080Ser 46e TCCrTCT Common 3/55
Lys2106Lys 46e AAArAAG Common 40/55
Asn2173Asn 48 AACrAAT Common 3/55
IVS48/25a/gc 48 CTGgt...gcct(a/g)gtg Common 3/55
a Common polymorphisms found in chromosomes of three or more different origins.
b Estimated from 55 unrelated chromosomes included in SSCP screening.
c IVS Å intronic splicing mutation.
d Reported by Weston et al. (1996).
e Reported by Levy et al. (1997).
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close origins. One partial similarity was also observed ties would seriously impair the proper construction of
an affective myosin VIIA mRNA. The second head mu-between two haplotypes of diverse origins, one from
Bulgaria and the other from Iran. All these similarities tation is the Gly214Arg substitution in exon 7, which
occurs within a highly conserved heptapeptide sequencecan be explained by ancestral recombination events and,
possibly, by migration patterns of Jewish communities. that is invariant in all myosins of all classes (Weil et
al 1995). This mutation resides C-terminal to the ATPHaplotypes that shared the same mutation—haplotypes
1–5, haplotypes 6 and 7, haplotypes 11 and 12, and binding loop, at the base of the ATP binding pocket. In
light of the absolute evolutionary conservation of resi-haplotypes 14 and 15—also shared most intragenic
polymorphisms and some other allelic similarities. This dues within this region, it is expected that the Gly214-
Arg mutation would severely impair the ATP-bindingobservation supports the assumption that each of these
mutations arose as a single and ancient mutational function of the protein. The third head mutation is the
Ala397Asp substitution in exon 11, which lies betweenevent, and it suggests that common USH1B alleles can
be deﬁned within populations. Such relative homogene- the ATP- and the actin-binding sites within a relatively
nonconserved region of the protein. However, this sub-ity of USH1B, which was not reﬂected in ﬁndings re-
ported by Weston et al. (1996), is most likely related to stitution was found in a homozygous state in USH1B-
affected individuals, and, in addition, it was shown tothe relative isolation of and marriage patterns among
Jewish communities. be very rare, occurring in only one control chromosome
(of Iranian origin) of ú200 tested by ASO analysis. InMutation analysis detected eight different novel muta-
tions. None of the already known 20 USH1B mutations this substitution, an alanine, which is a small and simple
amino acid with an aliphatic residue, is replaced bypreviously reported were identiﬁed among the families
included in this work. aspartate, which is a larger amino acid with a negatively
charged residue. Such a change might alter the three-These results demonstrate the diversity of mutations
responsible for USH1B and can be attributed to differ- dimensional structure of the N-terminal domain and
hence might have a crucial effect on the function of theences in mutation spectrum among populations. Patients
screened in other studies were of northern and western protein motor domain.
The head domain of human myosin VIIA is followedEurope and American origins, whereas affected individ-
uals studied by us are from eastern Europe, northern by a neck (regulatory) region containing ﬁve consecutive
repeats of the IQ motif (Weil et al. 1996). Two of theAfrica, and the Middle East.
Exploring the location and nature of myosin VIIA eight mutations reported in this work are located in the
neck domain. The ﬁrst is IVS18/1gra, which lies in themutations might shed more light on both the molecular
basis of the USH1B disorder and the role of myosin splice-donor region of exon 18. This transition, as has
been described for the one discussed above, is expectedVIIA in cellular function. Human myosin VIIA is typical
of the unconventional-myosins group (Weil et al. 1996) to cause a splicing defect, which would seriously impair
the proper construction of an affective myosin VIIAAll myosins are actin-based molecular motors that inter-
act with actin ﬁlaments, converting energy from ATP mRNA. The second neck mutation is the Ala826Thr
substitution in exon 21, which lies within the C-terminalhydrolysis into mechanical force used to perform diverse
cellular functions. Three different functional domains part of the myosin VIIA fourth IQ motif (in a series of
ﬁve). This motif is one of the three motifs that match theare deﬁned within the myosin heavy chains: an N-termi-
nal head domain (motor domain) harboring a typical consensus sequence of calmoduline-binding IQ motifs
(Wolenski 1995). Thus, the AlarThr change in codonATP binding site and an actin-binding site, a neck region
(regulatory domain) containing at least one IQ motif, 826 is expected to impair the calmoduline chain–bind-
ing function of the protein.and a tail domain that varies dramatically, in both length
and sequence, from one unconventional myosin to an- The human myosin VIIA possesses the longest tail
(1,360 amino acids) of all unconventional myosins iden-other and that is thought to be a speciﬁc membrane
binder (Cheney et al. 1993; Titus 1997). A schematic tiﬁed so far (Weil et al. 1996). Three mutations, all of
which are predicted to result in a truncated protein, weredistribution of mutation (detected in this study) along
the human myosin VIIA gene is shown in ﬁgure 2. located in the tail domain. The ﬁrst is the Arg1861stop
mutation in exon 40. This nonsense mutation wouldThree of the eight novel mutations are located in the
motor (head) domain. The ﬁrst is the IVS5/1gra transi- result in a truncated protein that lacks ú25% of the
normal tail domain, including its C-terminal part. Thetion, which lies in the splice-donor site of exon 5. The
great majority of point mutations identiﬁed within do- C-terminal part of myosin-VIIA is hydrophilic, more
basic than the rest of the tail, and shares homology withnor splice-sites (ss) occur in the /1G residue, and in
64% of these cases the substituting base is an adenosine the membrane-binding domain of various members of
the band-4.1 protein superfamily (Rees et al. 1990; Ta-(Krawczak et al. 1992). This IVS5/1gra transition is
expected to result either in exon skipping or in keuchi et al. 1994). Therefore, the Arg1861stop muta-
tion is predicted to impair the membrane-binding func-frameshift due to cryptic splice-site usage. Both possibili-
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Figure 2 Schematic representation of the relative linear location of each mutation along the myosine VIIA gene. The gene structure is
according to Chen et al. (1996) and Weil et al. (1996). ‘‘2119–2215Del2kb’’ denotes a large (2-kb) genomic deletion.
tion of the protein. The second tail mutation is a single main. These results are consistent with the mutation
cytosine deletion at codon 2065 in a CCCC string in distribution described for the b-cardiac myosin II (Ray-
exon 45, which also encodes a part of the second region ment et al. 1995).
homologous to the band-4.1 protein superfamily in the The mutations described were observed in a total of 42
myosin VIIa tail. This deletion is expected to cause a affected individuals from 15 USH1B families, including 1
frameshift that will lead to the formation of a UAA stop singleton case. In 14 of these families, mutations have been
codon 64 amino acids downstream from the deletion found in both alleles. Most affected individuals were ho-
and would therefore result in a truncated protein that mozygous for the same mutation, except for one patient
lacks the last 214 amino acids at the C-terminal end. whowas a compound heterozygote for two differentmuta-
Such a defect is expected to impair the membrane-bind- tions. In three additional USH1 families and in 10 USH1-
ing function of the protein, as described above. The third singleton cases, no myosin VIIA mutations were detected.
tail mutation is a large genomic deletion that includes None of these cases are consanguineous, and, in four of
exons 47, 48, all the translated part of exon 49, and the them, only a partial haplotype homozygosity has been
introns between them. This deletion spans the last third found in the myosin VIIA locus. In these three families
(96 amino acids) of the second region homologous to (each of which includes one affected child and two or three
the band-4.1 protein superfamily and thus is also ex- healthy siblings), haplotype analysis suggested linkage to
pected to have an impairing effect on the membrane- the USH1B locus, with a relatively low LOD score due to
binding function of the protein. The two small repeats the small number of members in each family. In all the
(TGGGCC and TGATG) that were found near the edges
singleton cases, as well as in the three small families, the
of this deletion in the normal genomic sequence could
possible involvement of another USH1 locus cannot behave been involved in recombination and loop-fragment
ruled out. However, even if these cases are actually linkedexcision, leading to the formation of this deletion.
to the USH1B locus, undetected myosin VIIA mutationsNo signiﬁcant difference was found in mutation distri-
might be located within uncharacterized regions of thebution among the three deﬁned domains of the human
gene, including the promotor region, unexplored intronmyosin VIIA gene. This result does not agree with the
sequences, and unexplored 3 and 5UTRs. Another possi-Weston et al.’s (1996) expectation that the majority of
ble explanation for the lack of detection of mutationsmutations would be found in the tail domain. Further-
might be the limitations of the SSCP technique. One ofmore, when also considering the mutations described by
these limitations is that SSCP cannot detect the presenceLevy et al. (1997), we get the following distribution:
of relatively large hemizygous deletions, as were observed8:2:6, for head, neck, and tail domains, respectively. In
in a homozygous state in the Jewish Tunisian family pre-view of the fact that the tail segment of the human myo-
sented in this work. Southern blot analysis performed insin VIIA consists of more than half the gene (Weil et
an attempt to overcome this limitation has not yet revealedal. 1996), such a distribution actually shows that the
any such deletions.majority of mutations are located within the head do-
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Appendix
Table A1
Summary of Data and Results for All USH1B Families
No. of
Family Ethnic Origin Affected Individuals Consanguinitya Haplotype(s) Genotype(s) Mutation
1 Algeria 1 / 1 Homozygote Ala826Thr
2 Algeria, Morocco 1 0 1, 2 Heterozygote Ala826Thr
3 Bulgaria, Hungary 2 0 12 Heterozygote Ala397Asp
13 Unknown
4 Iran 2 // 11 Homozygote Ala397Asp
5 Latvia, Poland 4 0 14, 15 Heterozygote IVS18/1gra
6 Morocco 4 // 2 Homozygote Ala826Thr
7 Morocco 2 / 3 Homozygote Ala826Thr
8 Morocco 2 / 4 Homozygote Ala826Thr
9 Morocco 2 ///0 4 Homozygote Ala826Thr
10 Morocco 2 ////0 8 Homozygote, Gly214Arg
Heterozygote
4 Heterozygote Ala826Thr
11 Morocco 2 /// 6 Homozygote 2065delC
12 Morocco 1 // 7 Homozygote 2065delC
13 Samaria 16 // 16 Homozygote Arg1861stop
14 Tunis 2 0 9 Homozygote 2119–2215del2kbb
15 Tunis 2 // 10 Homozygote IVS5/1gra
a / Å second-cousin marriage; // Å ﬁrst-cousin marriage; /// Å uncle-niece marriage; and 0 Å no consanguinity.
b IVS Å intronic splicing mutation.
c del2kb Å large genomic deletion including intronic sequences.
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